NAT2 fast acetylator genotypes are associated with an increased risk for lung cancer with wildtype epidermal growth factor receptors in Taiwan

Lung Cancer

Volumn 64, Issue 1, 2009, Pages 9-12

  Lee, Chun Nin ^a,b   Yu, Ming Chih ^a,b   Bai, Kuan Jen ^a,b   Chang, Jer Hua ^a,b   Fang, Chia Lang ^a   Hsu, Han Lin ^a,b   Huang, Biing Shiung ^c   Lu, Pei Chih ^b   Liu, H Eugene ^b,d  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

EGFR mutations; Lung cancer; NAT2 polymorphisms

Indexed keywords

ARYLAMINE ACETYLTRANSFERASE; EPIDERMAL GROWTH FACTOR RECEPTOR;

ACETYLATOR PHENOTYPE; ADULT; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK POPULATION; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TAIWAN;

ACETYLATION; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RISK ASSESSMENT; RISK FACTORS;

EID: 61449201882     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.07.001     Document Type: Article

References (21)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics. CA Cancer J Clin 55 (2005) 74-108
2. Hsieh R.K., Lim K.H., Kuo H.T., Tzen C.Y., and Huang M.J. Female sex and bronchioloalveolar pathologic subtype predict EGFR mutations in non-small cell lung cancer. Chest 128 (2005) 317-321
3. Shigematsu H., Lin L., Takahashi T., Nomura M., Suzuki M., Wistuba I.I., et al. Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers. J Natl Cancer Inst 97 (2005) 339-346
4. Pao W., Miller V., Zakowski M., Doherty J., Politi K., Sarkaria I., et al. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib. Proc Natl Acad Sci USA 101 (2004) 13306-13311
5. Sharma S.V., Bell D.W., Settleman J., and Haber D.A. Epidermal growth factor receptor mutations in lung cancer. Nat Rev Cancer 7 (2007) 169-181
6. Das A.K., Sato M., Story M.D., Peyton M., Graves R., Redpath S., et al. Non-small cell lung cancers with kinase domain mutations in the epidermal growth factor receptor are sensitive to ionizing radiation. Cancer Res 66 (2006) 9601-9608
7. Inatomi H., Katoh T., Kawamoto T., and Matsumoto T. NAT2 gene polymorphism as a possible marker for susceptibility to bladder cancer in Japanese. Int J Urol 6 (1999) 446-454
8. Su H.J., Guo Y.L., Lai M.D., Huang J.D., Cheng Y., and Christiani D.C. The NAT2* slow acetylator genotype is associated with bladder cancer in Taiwanese, but not in the Black Foot Disease endemic area population. Pharmacogenetics 8 (1998) 187-190
9. Osawa Y., Osawa K.K., Miyaishi A., Higuchi M., Tsutou A., Matsumura S., et al. NAT2 and CYP1A2 polymorphisms and lung cancer risk in relation to smoking status. Asian Pac J Cancer Prev 8 (2007) 103-108
10. Chiou H.L., Wu M.F., Chien W.P., Cheng Y.W., Wong R.H., Chen C.Y., et al. NAT2 fast acetylator genotype is associated with an increased risk of lung cancer among never-smoking women in Taiwan. Cancer Lett 223 (2005) 93-101
11. Seow A., Zhao B., Poh W.T., Teh M., Eng P., Wang Y.T., et al. NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore. Carcinogenesis 20 (1999) 1877-1881
12. Kim Y.T., Kim T.-Y., Lee D.S., Park S.J., Park J.-Y., Seo S.-J., et al. Molecular changes of epidermal growth factor receptor (EGFR) and KRAS and their impact on the clinical outcomes in surgically resected adenocarcinoma of the lung. Lung Cancer 59 (2008) 111-118
13. Liu H.E., Hsiao P.-Y., Lee C.-C., Lee J.-A., and Chen C.Y. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population. Cancer Epidemiol Biomarkers Prev 17 (2008) 661-665
14. Lin H.J., Han C.-Y., Lin B.K., and Hardy S. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyltransferase (NAT2) gene. Pharmacogenetics 4 (1994) 125-134
15. Matsuo K., Ito H., Yatabe Y., Hiraki A., Hirose K., Wakai K., et al. Risk factors differ for non-small-cell lung cancer cells with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese. Cancer Sci 98 (2007) 96-101
16. Lilla C., Verla-Tebit E., Risch A., Jaeger B., Hoffmeister M., Brenner H., et al. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev 15 (2006) 99-106
17. Huang C.-C., Chien W.-P., Wong R.-H., Cheng Y.-W., Chen M.-C., Chou M.-C., et al. NAT2 fast acetylator genotype is associated with an increase risk of colorectal cancer in Taiwan. Dis Colon Rectum 50 (2007) 981-989
18. Purewal M., Velasco M., Fretland A.J., Hein D.W., and Wargovich M.J. 2-Amino-1-methyl-6-phenylimidazol[4,5-b]pyridine induces a higher number of aberrant crypt foci in Fischer 344 (rapid) than in Wistar Kyoto (slow) acetylator inbred rats. Cancer Epidemiol Biomarkers Prev 9 (2000) 529-532
19. Gemignani F., Landi S., Szeszenia-Dabrowska N., Zaridze D., Lissowska J., Rudnai P., et al. Development of lung cancer before the age of 50: the role of xenobiotic metabolizing genes. Carcinogenesis 28 (2007) 1287-1293
20. Sorensen M., Autrup H., Tjonneland A., Overvad K., and Raaschou-Nielsen O. Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer Lett 221 (2005) 185-190
21. Matsuo K., Hiraki A., Ito H., Kosaka T., Suzuki T., Hirose K., et al. Soy consumption reduces the risk of non-small-cell lung cancers with epidermal growth factor receptor mutations among Japanese. Cancer Sci 99 (2008) 1202-1208